LLY — Eli Lilly and Company stock price and chart

LLY

Eli Lilly and CompanyStock · HealthcareS&P 500 1.5% · US Stock Market 1.4% · Russell 1000 1.4% · Russell 3000 1.3% · MSCI World 1.0% · MSCI ACWI 0.8% · S&P 500 Equal Weight 0.2%

$1,115.70-0.65%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNAUNHJNJMRKABBVAMGN

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

100.0200.0300.0400.0500.0600.0700.0800.0900.01000.01100.01200.00100.0M200.0M$1115.70

2026-09-11

Price$1115.70

MA20$1082.89

MA50$975.57

Vol13.0M

What would $1,000 invested in LLY be worth today? →

LLY returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $1,115.70
Change YTD: +4.32%
Next earnings: Oct 29, 2026 · Before open
Market cap: 997.1B2016-09 85.1B2026-09 996.7B+1070.7% over the window
Enterprise value: 1T
Shares outstanding: 893.7M2016-06 1.1B2026-06 893.7M-15.7% over the window
52W low: $712.05
52W high: $1,292.65
From 52W high: -13.69%
From 52W low: +56.69%
52W range: 70%
Beta: 0.50

Volume

Rel volume: 0.68×
30D volume: 2.7M
30D $ vol: 3.2B

Fundamentals

Sales (ttm): 79.7B2016-06 20.6B2026-06 79.7B+286.6% over the window
Sales/share: $89.142016-06 $19.442026-06 $89.14+358.6% over the window
EPS (ttm): $29.792016-06 $2.322026-06 $29.79+1184.1% over the window
FCF (ttm): 16.8B
FCF/share: $18.81
Book value/share: $37.912016-06 $13.812026-06 $37.91+174.6% over the window
Net margin: 33.53%2016-06 12.0%2026-06 33.5%+180.2% over the window
ROE: 78.84%2016-06 16.8%2026-06 78.8%+368.0% over the window
ROA: 18.77%2016-06 6.8%2026-06 18.8%+177.7% over the window
Debt / equity: 1.41×2016-06 0.592026-06 1.41+138.1% over the window
Current ratio: 1.352016-06 1.542026-06 1.35-12.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +49.62%2025-06-30 → 2026-06-3053.3B → 79.7B (+49.6% total)+39.22%2023-06-30 → 2026-06-3029.5B → 79.7B (+169.9% total)+24.42%2021-06-30 → 2026-06-3026.7B → 79.7B (+198.1% total)+14.48%2016-06-30 → 2026-06-3020.6B → 79.7B (+286.6% total)
Net income: +93.65%2025-06-30 → 2026-06-3013.8B → 26.7B (+93.6% total)+60.18%2023-06-30 → 2026-06-306.5B → 26.7B (+311.1% total)+34.50%2021-06-30 → 2026-06-306.1B → 26.7B (+340.0% total)+26.91%2016-06-30 → 2026-06-302.5B → 26.7B (+983.2% total)
Shares: -0.68%2025-06-30 → 2026-06-30899.8M → 893.7M (-0.7% total)-0.33%2023-06-30 → 2026-06-30902.7M → 893.7M (-1.0% total)-0.37%2021-06-30 → 2026-06-30910.4M → 893.7M (-1.8% total)-1.69%2016-06-30 → 2026-06-301.1B → 893.7M (-15.7% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +94.84%2025-06-30 → 2026-06-30$15.30 → $29.79 (+94.8% total)+60.60%2023-06-30 → 2026-06-30$7.19 → $29.79 (+314.3% total)+34.96%2021-06-30 → 2026-06-30$6.66 → $29.79 (+347.6% total)+29.08%2016-06-30 → 2026-06-30$2.32 → $29.79 (+1184.1% total)
Sales/share: +50.64%2025-06-30 → 2026-06-30$59.19 → $89.14 (+50.6% total)+39.69%2023-06-30 → 2026-06-30$32.70 → $89.14 (+172.6% total)+24.88%2021-06-30 → 2026-06-30$29.36 → $89.14 (+203.7% total)+16.45%2016-06-30 → 2026-06-30$19.44 → $89.14 (+358.6% total)
Book value/share: +86.75%2025-06-30 → 2026-06-30$20.31 → $37.91 (+86.7% total)+45.69%2023-06-30 → 2026-06-30$12.26 → $37.91 (+209.3% total)+39.89%2021-06-30 → 2026-06-30$7.08 → $37.91 (+435.5% total)+10.63%2016-06-30 → 2026-06-30$13.81 → $37.91 (+174.6% total)
Dividend/share: +15.36%2025-06-30 → 2026-06-30$5.80 → $6.69 (+15.3% total)+15.25%2023-06-30 → 2026-06-30$4.37 → $6.69 (+53.1% total)+10.67%2021-06-30 → 2026-06-30$4.03 → $6.69 (+66.0% total)+12.72%2016-06-30 → 2026-06-30$2.02 → $6.69 (+231.2% total)
Price: +47.56%2025-09-11 → 2026-09-11$756.28 → $1,115.70 (+47.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+23.27%2023-09-11 → 2026-09-11$595.56 → $1,115.70 (+87.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+36.02%2021-09-10 → 2026-09-11$239.50 → $1,115.70 (+365.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+30.43%2016-09-09 → 2026-09-11$78.24 → $1,115.70 (+1326.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +48.50%2025-09-11 → 2026-09-11$751.54 → $1,115.70 (+48.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.12%2023-09-11 → 2026-09-11$583.42 → $1,115.70 (+91.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+37.26%2021-09-10 → 2026-09-11$228.87 → $1,115.70 (+387.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.48%2016-09-09 → 2026-09-11$66.91 → $1,115.70 (+1567.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 37.5×2016-09 34.832026-09 37.31+7.1% over the window
Fwd P/E: 23.8×
P/S (ttm)Market cap ÷ TTM revenue.: 12.5×2016-09 4.092026-09 12.51+206.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 29.4×2016-09 5.462026-09 29.42+438.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 59.3×
EV/Sales (ttm): 13.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 1.69%
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.60%
Dividend/share (fwd): $6.69
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($6.2B) ÷ today's market cap ($997.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.62%2016-06 0.7%2026-06 0.6%-21.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $6.2B + TTM dividends $5.8B) ÷ today's market cap ($997.1B). Same caveat as the cash buyback yield.: 1.20%2016-06 3.2%2026-06 1.1%-65.8% over the window

Vs own 10Y history

P/E: 37th
P/S: 69th
P/B: 39th

Bar = where today’s multiple sits in LLY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.65%

-3.79%

-8.44%

-3.76%

YTD

+4.32%

+48.78%

+349.78%

Financial statements

Open full LLY financials →

Loading financial statements…

Ticker	Name	1M	1D
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%
ABT	Abbott Laboratories	-8.08%	-1.36%

Eli Lilly and Company (LLY) trades at $1,115.70 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes LLY’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full LLY financial statements →

LLY — Eli Lilly and Company price, chart and key statistics